항진균제 시장 규모, 점유율, 성장 분석 : 약제 유형별, 치료 적응증별, 유형별, 투여 경로별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Antifungal Agents Market size was valued at USD 15.5 Billion in 2024 and is poised to grow from USD 16.12 Billion in 2025 to USD 22.06 Billion by 2033, growing at a CAGR of 4% during the forecast period (2026-2033).

The global antifungal agents market is poised for significant growth driven by the increasing prevalence of fungal infections and heightened demand for treatments. Continuous advancements in drug discovery and development are expected to further enhance market dynamics. Substantial investments in antifungal research are vital contributors to sales growth, particularly in underdeveloped and developing regions, which present promising opportunities for providers. However, challenges such as antifungal resistance and a limited range of effective agents may pose substantial hurdles to sustainable market expansion. Overall, the landscape for antifungal agents appears optimistic, with potential for innovation and market penetration, despite the existing limitations that could impact long-term growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antifungal Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antifungal Agents Market Segments Analysis

Global Antifungal Agents Market is segmented by Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel and region. Based on Drug Type, the market is segmented into Systemic Azoles & Polyenes, Topical Azoles & Polyenes, Systemic Echinocandins & Antimetabolics and Others. Based on Therapeutic Indication, the market is segmented into Dermatophytosis, Candidiasis, Aspergillosis and Others. Based on Type, the market is segmented into Prescription and Over the counter (OTC). Based on Route of Administration, the market is segmented into Oral, Topical and Parenteral. Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antifungal Agents Market

The rising prevalence of antibiotic resistance, coupled with the increasing occurrence of infectious chronic diseases, contributes significantly to the surge in fungal infections among patients. This growing health challenge is anticipated to drive the demand for antifungal agents as healthcare professionals seek effective treatments to combat these resilient pathogens. As more individuals are affected by fungal infections, the need for innovative and potent antifungal therapies becomes critical, creating a dynamic market environment. Consequently, the escalating incidence of these health issues is expected to enhance the overall outlook for antifungal agents in various healthcare settings.

Restraints in the Global Antifungal Agents Market

The emergence of fungal pathogens exhibiting resistance to commonly utilized antifungal agents poses a significant challenge to the Global Antifungal Agents market. As resistance rates increase, the effectiveness of these treatments diminishes, leading to a concerning trend where antifungal therapies become less reliable. This escalating antifungal resistance may hinder market expansion by limiting the efficacy of existing products and creating a demand for more innovative solutions. Consequently, pharmaceutical companies must prioritize research and development to combat this issue and ensure the continued effectiveness of antifungal agents in addressing infections caused by resistant strains.

Market Trends of the Global Antifungal Agents Market

The Global Antifungal Agents market is witnessing a notable trend towards the integration of personalized medicine. Companies in the antifungal sector are increasingly collaborating with personalized medicine firms to create tailored treatment options for patients suffering from diverse fungal infections. This strategic partnership allows antifungal agents to leverage advancements in genetic profiling and biomarkers, enabling the development of specialized therapies that cater to individual patient profiles. By focusing on personalized approaches, companies aim to optimize treatment efficacy and improve patient outcomes, which in turn drives revenue generation and market growth. This trend reflects a broader shift towards more customized healthcare solutions in the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement
• Trade Analysis
• Customer & Buying Criteria Analysis
• Raw Material Analysis

Global Antifungal Agents Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Systemic Azoles & Polyenes
• Topical Azoles & Polyenes
• Systemic Echinocandins & Antimetabolics
• Others

Global Antifungal Agents Market Size by Therapeutic Indication & CAGR (2026-2033)

• Market Overview
• Dermatophytosis
• Candidiasis
• Aspergillosis
• Others

Global Antifungal Agents Market Size by Type & CAGR (2026-2033)

• Market Overview
• Prescription
• Over the counter (OTC)

Global Antifungal Agents Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Topical
• Parenteral

Global Antifungal Agents Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospitals Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Global Antifungal Agents Market Size & CAGR (2026-2033)

• North America (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
  • US
  • Canada
• Europe (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadila Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCYNEXIS, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arcadia Consumer Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leadiant Biosciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apotex Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Inc. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations